跳至主要内容
临床试验/NCT06845878
NCT06845878已完成1 期

A Conversational Agent To Support Follow-up Care For Individuals In Recovery For Substance Use Disorder

Dimagi Inc.1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2025年3月7日最近更新:
干预措施

试验速览

阶段
1 期
状态
已完成
发起方
Dimagi Inc.
入组人数
55
试验地点
1
主要终点
Change in SUD severity

研究概览

简要总结

The goal of this clinical trial is to learn if/how an AI chatbot can support patients who in recovery for substance use, specifically those who are receiving medication for opioid use disorder.

Can the chatbot help lower drug use? Can the chatbot help improve clinical appointment adherence? Can the chatbot help patients build self-efficacy in leading their own recovery journey? Will the chatbot help reduce workload burden for primary care teams? Can the chatbot serve as a safe, useful and engaging tool to support patients?

Researchers will investigate the effects of using a chatbot to support follow-up care for patients in opioid use recovery.

Participants will:

  • Receive access to a chatbot for 12 weeks that they can use to prepare for upcoming clinical appointments, find community resources, learn about urge-surfing and wellness techniques, and query for assistance with other recovery-related information and tasks
  • Complete surveys and provide user feedback

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-65 years old
  • Comfortable with reading, understanding, and communicating in English
  • Receiving medication treatment for OUD at MGH?
  • Able to participate in a remote interview?
  • Own or have reliable access to Wi-Fi or a cellular network
  • Willing to use a mobile device to access the chatbot?

排除标准

  • Has any cognitive, visual, or auditory impairments that may prevent the participant from using the chatbot on a mobile device?
  • Unstable medical condition that compromises the ability to safely participate

研究组 & 干预措施

Chatbot

Experimental

Participants will receive access to a chatbot for 12 weeks that can be used from a mobile device to support follow-up care and recovery needs.

干预措施: chatbot (Other)

结局指标

主要结局

Change in SUD severity

时间窗: 12 weeks

Addiction Severity Index (ASI) Drugs composite score; Scored 0-7 with higher scores indicating increasing severity

Change in psychological health (Anxiety)

时间窗: 12 weeks

General Anxiety Disorder-7 (GAD-7); scored 0-21 with higher scores indicating increasing anxiety

Change in psychological health (Depression)

时间窗: 12 weeks

Patient Health Questionnaire-8 (PHQ-8); scored 0-24 with higher scores indicating more severe depression

Change in self-efficacy for managing chronic conditions (Emotions)

时间窗: 12 weeks

PROMIS Short Form 8a (Managing Emotions); scored from 8-40 with higher scores indicating higher confidence managing emotions

Change in self-efficacy for managing chronic conditions (Social Interactions)

时间窗: 12 weeks

PROMIS Short Form 8a (Social Interactions); scored from 8-40 with higher scores indicating higher confidence with managing social interactions

次要结局

  • Change in social needs(12 weeks)
  • Change in quality of life(12 weeks)
  • Chatbot usability(End of 12 week intervention)
  • User Satisfaction(End of 12 week intervention)

研究者

发起方
Dimagi Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验